Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BSX and other ETFs, options, and stocks.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
48,000
Employees48,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
48,000
Employees48,000

BSX Key Statistics

Market cap
98.97B
Market cap98.97B
Price-Earnings ratio
62.84
Price-Earnings ratio62.84
Dividend yield
Dividend yield
Average volume
5.87M
Average volume5.87M
High today
$68.03
High today$68.03
Low today
$66.91
Low today$66.91
Open price
$67.84
Open price$67.84
Volume
6.97M
Volume6.97M
52 Week high
$69.21
52 Week high$69.21
52 Week low
$48.35
52 Week low$48.35

BSX News

Benzinga 1d
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'

FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious' On Wednesday, Boston Scientific Corporation (NYSE:BSX) said it recall...

FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'
Yahoo Finance 2d
Boston Scientific recalls blood-blocking agent linked to 2 deaths - Yahoo Finance

Dive Brief: Boston Scientific has recalled an agent used to block blood flow to specific vessels due to a safety problem that has been tied to seven injuries a...

Boston Scientific recalls blood-blocking agent linked to 2 deaths - Yahoo Finance
Reuters 2d
UPDATE 1-FDA classifies recall of Boston Scientific device as 'most serious'

(Adds details from FDA in paragraphs 2-6, company's response in last two paragraphs) April 17 (Reuters) - The U.S. Food and Drug Administration on Wednesday cl...

UPDATE 1-FDA classifies recall of Boston Scientific device as 'most serious'

Analyst ratings

88%

of 34 ratings
Buy
88.2%
Hold
8.8%
Sell
2.9%

More BSX News

TipRanks 2d
Boston Scientific recalls 1,594 Obsidio Embolic devices in U.S.

Boston Scientific Corporation is recalling 1,594 Obsidio Embolic devices in the U.S. by issuing a correction, according to a post from the FDA. An investigation...

Investor's Business Daily 3d
Boston Scientific Joins Elite List Of Stocks With 95-Plus Composite Rating - Investor's Business Daily

On Wednesday, Boston Scientific (BSX) got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96. X The revised score means the stock currently tops...

Boston Scientific Joins Elite List Of Stocks With 95-Plus Composite Rating - Investor's Business Daily
TipRanks 5d
Boston Scientific price target raised to $78 from $70 at RBC Capital

RBC Capital raised the firm’s price target on Boston Scientific to $78 from $70 and keeps an Outperform rating on the shares as part of a broader research note...

TipRanks 5d
Integer upgraded to Buy from Neutral at BofA

BofA upgraded Integer (ITGR) to Buy from Neutral with a price target of $135, up from $105. Integer should benefit from the emergence of pulsed field ablation,...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.